2014
Reduced bioenergetics and toll-like receptor 1 function in human polymorphonuclear leukocytes in aging
Qian F, Guo X, Wang X, Yuan X, Chen S, Malawista SE, Bockenstedt LK, Allore HG, Montgomery RR. Reduced bioenergetics and toll-like receptor 1 function in human polymorphonuclear leukocytes in aging. Aging 2014, 6: 131-139. PMID: 24595889, PMCID: PMC3969281, DOI: 10.18632/aging.100642.Peer-Reviewed Original ResearchConceptsToll-like receptor 1Polymorphonuclear leukocytesOlder adultsChemokine IL-8Loss of CD62LAge-dependent deficienciesPotential therapeutic opportunitiesHuman polymorphonuclear leukocytesTLR1 expressionIL-8PMN functionPMN activationMultiple pathwaysImmune functionYoung donorsP38 MAP kinaseReceptor 1Bacterial infectionsTherapeutic opportunitiesProgressive declineGlucose uptakeReduced expressionAdultsStimulationLeukocytes
2003
Increased leukocyte-platelet adhesion in patients with graft occlusion after peripheral vascular surgery
Esposito CJ, Popescu WM, Rinder HM, Schwartz JJ, Smith BR, Rinder CS. Increased leukocyte-platelet adhesion in patients with graft occlusion after peripheral vascular surgery. Thrombosis And Haemostasis 2003, 90: 1128-1134. PMID: 14652647, DOI: 10.1160/th03-04-0226.Peer-Reviewed Original ResearchConceptsPeripheral vascular diseasePeripheral vascular surgeryGraft occlusionLeukocyte-platelet adhesionOcclusion groupPlatelet turnoverVascular surgeryPMN activationPeripheral vascular surgery patientsLower extremity peripheral vascular diseaseEtiology of thrombosisVascular surgery patientsLate graft occlusionEarly postoperative periodSurface CD11b expressionProgression of atherosclerosisGraft lossPVD patientsGraft patientsPostoperative dayPostoperative periodSurgery patientsAcute thrombosisGraft patencyVascular disease
2001
COMBINATION THERAPY THAT TARGETS SECONDARY PULMONARY CHANGES AFTER ABDOMINAL TRAUMA
Davis K, Fabian T, Ragsdale D, Trenthem L, Croce M, Proctor K. COMBINATION THERAPY THAT TARGETS SECONDARY PULMONARY CHANGES AFTER ABDOMINAL TRAUMA. Shock 2001, 15: 479-484. PMID: 11386622, DOI: 10.1097/00024382-200115060-00012.Peer-Reviewed Original ResearchMeSH KeywordsAbdominal AbscessAbdominal InjuriesAminoimidazole CarboxamideAnimalsAnti-Inflammatory AgentsBlood PressureCapillariesDisease Models, AnimalHemodynamicsInflammationLactatesLungLung InjuryNeutrophilsPulmonary AlveoliPulmonary ArteryResuscitationRibonucleotidesShock, HemorrhagicSteroidsSwineConceptsSecondary lung injuryAbdominal traumaG-CSFPMN activationLung injuryHemorrhagic shockAnalysis of BALLate septic complicationsLavage leukocyte countPulmonary reperfusion injurySecondary pulmonary changesAnti-inflammatory drugsAnti-inflammatory metabolitesWhite blood cellsNeutrophil sequestrationPulmonary contusionSeptic complicationsPMN infiltrationPulmonary changesReperfusion injurySecondary injuryResuscitation strategiesShed bloodCombination therapyEndogenous adenosine
1999
Role of C3 Cleavage in Monocyte Activation During Extracorporeal Circulation
Rinder C, Rinder H, Johnson K, Smith M, Lee D, Tracey J, Polack G, Higgins P, Yeh C, Smith MD B. Role of C3 Cleavage in Monocyte Activation During Extracorporeal Circulation. Circulation 1999, 100: 553-558. PMID: 10430771, DOI: 10.1161/01.cir.100.5.553.Peer-Reviewed Original ResearchConceptsMonocyte activationC5b-9CD11b upregulationComplement inhibitionExtracorporeal circulationPlatelet activationTerminal complement inhibitionMonocyte-platelet conjugatesComplement regulatory protein CD46Early complement componentsPMN elastase releaseGeneration of C3aMicrograms/mLCardiopulmonary bypassBlood cell activationPMN activationElastase releaseCell activationHuman volunteersMicrograms/Complement activationPrevents plateletComplement componentsWhole bloodCommon pathway
1998
C3- AND C5- CONVERTASE INHIBITION PREVENTS MONOCYTE AND PMN ACTIVATION DURING IN VITRO CARDIOPULMONARY BYPASS
Lee D, Smith M, Tracey J, Johnson K, Higgins P, Yeh C, Smith B, Rinder C. C3- AND C5- CONVERTASE INHIBITION PREVENTS MONOCYTE AND PMN ACTIVATION DURING IN VITRO CARDIOPULMONARY BYPASS. Anesthesia & Analgesia 1998, 86: 1sca.. DOI: 10.1213/00000539-199804001-00001.Peer-Reviewed Original ResearchCardiopulmonary bypassPMN activation
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply